HAPPENINGS
GREENVILLE, SC I November 13, 2024 - Samaritan Biologics, a leading medical technology company specializing in human amniotic allograft products, today announced that it is expanding its operations with a new manufacturing facility in Greenville County. This investment of $5 million will create 85 new jobs over the next several years, further solidifying the region's status as a hub for advanced life sciences and regenerative medicine.
Samaritan Biologics' new 11,000-square-foot facility, located on Clemson University's International Center for Automotive Research (CU-ICAR) campus, will feature five state-of-the art clean rooms designed to process human cellular tissue products. The company's focus on developing innovative, best-in-class products for wound care, surgical applications, and limb preservation will be enhanced through this expansion, leveraging Greenville's growing reputation in medical technology and research.
Samaritan Biologics is committed to helping the next generation of Med Tech innovators by providing customized internship experiences that fit within students schedules and provides them exposure to industry to complement their academic education. Samaritan has sponsored internships with Students from University of Florida, Clemson University, University of Georgia, University of Tennessee at Chattanooga, and Furman University.
Samaritan was proud to be recognized as the Powering Progress Sponsor for the 2022 JDRF Promise Galas in Memphis, Tennessee, and Greenville South Carolina and in attendance for both Gala’s Over 2.7M dollars was raised in Tennessee between the three Promise Gala’s and over $500,000 was raised in Greenville alone. Please plan to attend the 2023 JDRF Galas in Memphis and Greenville on April 29th.
Samaritan Biologics is all about Helping, Healing and Giving. One way Samaritan gives back is by providing mentoring and industry experience to the next generation of MedTech innovators via our student internship program. Samaritan has sponsored internships with Students from University of Florida, Clemson University, University of Georgia, University of Tennessee at Chattanooga, and Furman University.
Centers for Medicare & Medicaid Services approved a new Healthcare Common Procedure Coding System (HCPCS) Code Q4256 for MLG-COMPLETE™ for Samaritan Biologics effective April 1, 2022.
Samaritan Biologics, a socially responsible regenerative medicine company based in Memphis, Tennessee, launched EyeGenMD.com.
Samaritan Biologics, Memphis, TN successfully helped Juvenile Diabetes Research Foundation secure a collectible rare bottle of whiskey from Buffalo Trace Distillery in Frankfort, Kentucky to raise funds for research for type 1 diabetes.
Samaritan Biologics managing partner Jerry Chang was selected by PRISMA Health Systems to be part of the Covid-19 Rapid Innovations Task Force that was assembled to drive innovative responses to the unique challenges seen fighting this virus. Jerry took the lead on a project to create and supply over 250,000 face shields.
